Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient preference crossover study of Eucreas versus Victoza added to metformin in type 2 diabetes
2011-003818-16Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vildagliptin and liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novartis. Primary endpoint: Patient preference for one treatment. Started Oct 2011; status: completed.
02
Drugs
vildagliptinliraglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-003818-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003818-16.